Reach Us +1-504-608-239
Editor - Takefumi Komiya | University of Kansas Medical Center | 22388
ISSN: 2577-0535

Journal of Cancer Clinical Trials
Open Access

Like us on:

OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
All submissions of the EM system will be redirected to Online Manuscript Submission System. Authors are requested to submit articles directly to Online Manuscript Submission System of respective journal.
Relevant Topics

Takefumi Komiya

Takefumi Komiya
Takefumi Komiya
Assistant Professor
University of Kansas Medical Center
United States


Takefumi Komiya is currently a medical oncologist and an Assistant Professor in Division of Medical Oncology, University of Kansas Medical Center, Kansas, United States. He has obtained MD in Japan in 1990 and completed post-graduate medical training in both Japan and United States. He was also trained at National Cancer Institute for cancer genetics. Since 2013 he has been involved in Early Phase Clinical Trial and Thoracic Medical Oncology teams within his institution. His interest is development of clinical trials in cancer immunotherapy and targeted therapy in lung cancer. He is an active member of American Society of Clinical Oncology (ASCO), American Association for Cancer Research (AACR), and International Association for the Study of Lung Cancer (IASLC).

Research Interest

Lung cancer
Phase I studies


Rational Design of Combinations for the Treatment of Advanced Cancer

Takefumi Komiya
Short Communication: J Cancer Clin Trials 2016, 1:122
Leave Your Message 24x7